Today we reported our second-quarter financial results. $VTRS
Read our press release for more information, including non-GAAP financial measure reconciliations and risks related to fwd-looking statements. viatr.is/4wHcP5j
Viatris
@ViatrisInc
Leading with ingenuity and resolve, we empower people worldwide to live healthier at every stage of life. $VTRS
Joined November 2019
- Join us on August 6 at 8:30 a.m. ET for our Q2 2026 conference call. Register for the webcast here: investor.viatris.com
- Today we announced the U.S. FDA has approved our new combined hormonal contraceptive patch with low-dose estrogen. The approval of this non-invasive, once-weekly patch marks an important milestone in our efforts to advance women’s health. More info: viatr.is/4vVStEq
- Today we announced top-line results from our Phase 3 study in Japanese adults with primary IgA nephropathy. Read for more information here: viatr.is/21
- We look forward to being at #AANP2026 in Las Vegas. Stop by booth #917 to learn how we are advancing birth control options.
